{"nct_id":"NCT00760877","title":"Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)","status":"COMPLETED","status_verified_date":"2016-10","start_date":"2009-06","start_date_type":null,"primary_completion_date":"2015-07","primary_completion_date_type":"ACTUAL","completion_date":"2015-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}